These can include dry mouth, headaches, agitation, and in rare cases, an increased risk of seizures, which is dose-dependent
For instance, the costs associated with Ozempic injections are actually cheaper than a non-invasive gastric balloon
The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]
Semaglutide: GLP-1 Receptor Agonist Semaglutide activates a single receptor type: GLP-1 (Glucagon-like peptide-1): Slows gastric emptying, suppresses appetite at the hypothalamic level, and stimulates insulin secretion in a glucose-dependent manner Semaglutide has been studied extensively since 2017 and has the longest track record of any injectable GLP-1 agonist on the market
In early studies, people on higher doses of retatrutide lost more than 20 percent of their body weight on average, which is higher than the results seen with many current drugs
